Process Industries
Asahi Kasei Corp.
- 1,113.00 JPY
- -20.50
- -1.81%
Japan
Jul 23, 2019Ticker
TKS(3407)Prev. close
1,133.5Market cap (JPY)
1,589.86BMarket cap (USD)
14,704.63MShares
1,402.61M
In the news
- Toray plans European factory for electric-car battery separators Jul 13, 2019
- South Korea threatens retaliation over Japan export controls Jul 5, 2019
- Japan stock buybacks surge as ample cash is put to work May 23, 2019
- Mitsubishi Estate plans first-ever stock buyback May 15, 2019
- China's environmental campaign pushes companies to relocate Feb 10, 2019 See more articles on Asahi Kasei Corp.
Business Summary
Asahi Kasei Corp. is a holding company which provides monitoring, planning, and strategic management to its subsidiaries and affiliates. It operates through the following segments: Material, Homes, Health Care, and Other Businesses. The Material segment includes fibers, textiles, chemicals, and electronics. The Homes segment includes "Long Life Home" products and offers remodeling, real estate, and urban redevelopment. It also includes construction materials. The Health Care segment includes pharmaceuticals, medical care, and acute critical care. The Other Businesses segment includes engineering, employment agency, processing and sale of Asahi Kasei products, and temporary staffing. The company was founded on May 21, 1931 and is headquartered in Tokyo, Japan.
Financial Highlights
| Mar 2019 | JPY | USD |
| Revenue | 2,170.40B | 19,571.75M |
| Gross Profit | 715,748M | 6,454.30M |
| Operating income | 209,588M | 1,889.97M |
| Income before tax | 210,397M | 1,897.26M |
| Net income | 147,512M | 1,330.19M |
| EBITDA | 313,634M | 2,828.21M |
| Diluted EPS | 105.65 | 0.95 |
| Dividends Per Share | 34 | 0.30 |
| Total Assets | 2,575.20B | 23,266.05M |
| Total liabilities | 1,172.49B | 10,593.05M |
| Total equity | 1,381.48B | 12,481.23M |
| Operating cash flow | 212,062M | 1,912.28M |
| Currency in JPY | Currency in USD |
Historical Data
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
| Revenue | 1,986.40B | 1,940.91B | 1,882.99B | 2,042.21B | 2,170.40B |
| Gross Profit | 564,705M | 606,344M | 606,826M | 672,802M | 715,748M |
| Operating income | 157,933M | 165,203M | 159,230M | 198,475M | 209,588M |
| Income before tax | 158,440M | 146,389M | 157,388M | 218,333M | 210,397M |
| Net income | 105,652M | 91,754M | 115,000M | 170,249M | 147,512M |
| EBITDA | 253,311M | 274,835M | 268,423M | 311,938M | 313,634M |
| Diluted EPS | 75.62 | 65.69 | 82.34 | 121.92 | 105.65 |
| Dividends Per Share | 19 | 20 | 24 | 34 | 34 |
| Total Assets | 2,014.53B | 2,211.72B | 2,254.50B | 2,307.15B | 2,575.20B |
| Total liabilities | 916,809M | 1,154.33B | 1,086.38B | 1,001.93B | 1,172.49B |
| Total equity | 1,082.65B | 1,041.90B | 1,151.34B | 1,287.38B | 1,381.48B |
| Operating cash flow | 137,597M | 216,218M | 168,965M | 249,891M | 212,062M |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
| Revenue | 18,081.81M | 16,162.93M | 17,388.81M | 18,426.16M | 19,571.75M |
| Gross Profit | 5,140.38M | 5,049.32M | 5,603.84M | 6,070.44M | 6,454.30M |
| Operating income | 1,437.63M | 1,375.72M | 1,470.43M | 1,790.76M | 1,889.97M |
| Income before tax | 1,442.24M | 1,219.05M | 1,453.42M | 1,969.93M | 1,897.26M |
| Net income | 961.72M | 764.07M | 1,061.98M | 1,536.09M | 1,330.19M |
| EBITDA | 2,305.83M | 2,288.68M | 2,478.79M | 2,814.50M | 2,828.21M |
| Diluted EPS | 0.68 | 0.54 | 0.76 | 1.10 | 0.95 |
| Dividends Per Share | 0.17 | 0.16 | 0.22 | 0.30 | 0.30 |
| Total Assets | 16,798.25M | 19,678.17M | 20,232.43M | 21,693.96M | 23,266.05M |
| Total liabilities | 7,644.85M | 10,270.29M | 9,749.48M | 9,421.12M | 10,593.05M |
| Total equity | 9,027.75M | 9,269.99M | 10,332.44M | 12,105.18M | 12,481.23M |
| Operating cash flow | 1,252.51M | 1,800.55M | 1,560.33M | 2,254.67M | 1,912.28M |
Valuation Measures
| Mar 2019 | |
| PER | 10.80 |
| ROA | 6.04% |
| ROE | 11.05% |
| Operating margin | 9.65% |
| Profit margin | 6.79% |
Key executives
- Executive President & Representative Director: Hideki Kobori
- Director, Head-Information Technology & Finance: Yutaka Shibata
- Head-Risk, Compliance, Legal & General Affairs: Nobuyuki Kakizawa
- Representative Director & Executive Vice President: Shigeki Takayama
- Director & Senior Managing Executive Officer: Shuichi Sakamoto
Shareholders
- Capital Research & Management Co. (World Investors) (8.2%)
- Nippon Life Insurance Co. (4.6%)
- Capital Research & Management Co. (Global Investors) (3.6%)
- Asset Management One Co., Ltd. (3.3%)
- Sumitomo Mitsui Trust Asset Management Co., Ltd. (3.1%)
- Nomura Asset Management Co., Ltd. (2.5%)
- Sumitomo Mitsui Financial Group, Inc. (2.5%)
- The Vanguard Group, Inc. (2.3%)
- Asahi Kasei Employee Stock Ownership Plan (2.3%)
- Daiwa Asset Management Co. Ltd. (1.4%)
Contact Details
- Website:http://www.asahi-kasei.co.jp
- Address: Hibiya Mitsui Tower, 1-1-2 Yuraku-cho, Tokyo, 100-0006, Japan
- Phone: +81.3.6699.3000
Related Companies
- Asahikasei Haus SSI Co. Ltd.
- Polypore KK
- Asahi-Schwebel Co. Ltd.
- Asahi Kasei Plastics America, Inc.
- Asahi Kasei Corporate Venture Capital
- Asahi Kasei Board Incentive Plan
- Asahi-Schewebel Co., Ltd.
- Asahi Tokyo Investment Trust Management Co., Ltd.
- Asahi Kasei Europe GmbH
- Asahi Kasei (China) Investment Co. Ltd.
- Kyokuyo Textile (Thailand) Co. Ltd.
- Asahi Kasei Synthetic Rubber Europe NV/SA
- Asahi Kasei Deutschland GmbH
- Asahi Kasei E-Materials Korea, Inc.
- Asahi Kasei Medical Trading (Korea) Co. Ltd.
- Asahi Kasei Tibbi Cihazlar Tic Ltd. Sti
- Asahi Kasei (Suzhou) Plastics Compound Co. Ltd.
- Asahi Kasei EMD Taiwan Corp.
- Asahikasei Plastics (Hong Kong) Co. Ltd.
- Asahi Kasei Fibers Italia SRL
- Asahikasei Plastics (America), Inc.
- Asahi Kasei POM (Zhangjiagang) Co. Ltd.
- ASAHI KASEI MICROZA (Hangzhou) Co. Ltd.
- Asahi Kasei Bioprocess Europe NV/SA
- Asahi Kasei Medical Trading Taiwan Co. Ltd.
- Asahi Kasei Microdevices Korea Corp.
- Asahi Kasei Microdevices (Shanghai) Co. Ltd.
- Asahi Kasei Fibers International (Shanghai) Co. Ltd.
- Asahi Kasei Electronics Materials Changshu Co. Ltd.
- Asahi Kasei Performance Chemicals Corp.
Competitors
- Sumitomo Chemical Co., Ltd.
- Eternal Materials Co., Ltd.
- Covestro AG
- LG Chem Ltd.
- Trinseo SA
- Celanese Corporation
- thyssenkrupp AG
- Fresenius Medical Care AG & Co. KGaA
- Green Seal Holding Ltd.
- Everspin Technologies, Inc.
- CytoSorbents Corporation
- Cirrus Logic, Inc.
- DMC Global Inc.
- Nephros, Inc.
- PledPharma AB
- Stryker Corporation
Copyright © 2019 FactSet Research Systems Inc. All rights reserved.
Last Updated on 23 Jul, 2019